Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

被引：4

作者：

Girling, DJ ^{[1
]}

Thatcher, N ^{[1
]}

Clark, PI ^{[1
]}

Stephens, RJ ^{[1
]}

机构：

[1] CHRISTIE HOSP,MANCHESTER,LANCS,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 07期

关键词：

D O I：

10.1016/0959-8049(96)00071-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1263 / 1263

页数：1

共 7 条

[1] Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer [J].

Gridelli, C ;

Perrone, F ;

DAprile, M ;

Rossi, A ;

Palmeri, S ;

Curcio, C ;

Veltri, E ;

Ianniello, G ;

Lorusso, V ;

Palmieri, G ;

Rinaldi, L ;

DePlacido, S ;

Gallo, C ;

Bianco, AR .

EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) :2424-2426

[2] AN OVERVIEW OF PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER - A REPORT FROM THE SUBCOMMITTEE FOR THE MANAGEMENT OF LUNG-CANCER OF THE UNITED-KINGDOM COORDINATING COMMITTEE ON CANCER-RESEARCH [J].

RAWSON, NSB ;

PETO, J .

BRITISH JOURNAL OF CANCER, 1990, 61 (04) :597-604

[3] MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMEN IN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BY THE EUROPEAN LUNG-CANCER WORKING PARTY [J].

SCULIER, JP ;

PAESMANS, M ;

BUREAU, G ;

DABOUIS, G ;

LIBERT, P ;

VANDERMOTEN, G ;

VANCUTSEM, O ;

BERCHIER, MC ;

RIES, F ;

MICHEL, J ;

SERGYSELS, R ;

MOMMEN, P ;

KLASTERSKY, J .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1858-1865

[4] RANDOMIZED TRIAL COMPARING WEEKLY VERSUS 3-WEEK CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL [J].

SOUHAMI, RL ;

RUDD, R ;

DEELVIRA, MCR ;

JAMES, L ;

GOWER, N ;

HARPER, PG ;

TOBIAS, JS ;

PARTRIDGE, MR ;

DAVISON, AG ;

TRASK, C ;

SPIRO, SG .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1806-1813

[5] CHEMOTHERAPY DOSE INTENSITY IN SMALL-CELL LUNG-CANCER [J].

SOUHAMI, RL ;

DEELVIRA, MCR .

LUNG CANCER, 1994, 10 :S175-S185

[6]

Thatcher N, 1995, Clin Oncol (R Coll Radiol), V7, P293, DOI 10.1016/S0936-6555(05)80536-9

[7] THE FEASIBILITY OF USING GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TO INCREASE THE PLANNED DOSE INTENSITY OF DOXORUBICIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE (ACE) IN THE TREATMENT OF SMALL-CELL LUNG-CANCER [J].

THATCHER, N ;

ANDERSON, H ;

BLEEHEN, NI ;

GIRLING, DJ ;

LALLEMAND, G ;

MACHIN, D ;

STEPHENS, RJ .

EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) :152-156

← 1 →